Dessislava Marinova

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials

Ainhoa Arbués, Jesús Gonzalo‐Asensio, Dessislava Marinova et al. · Vaccine · 2013 · 254 citations · Full text

Vaccination, Pulmonary Tuberculosis, Vaccine Development +11

Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial

François Spertini, R Audran, Reza Chakour et al. · The Lancet Respiratory Medicine · 2015 · 174 citations · Full text

Vaccination, Vaccine Safety, Pulmonary Tuberculosis +8

ESX-1-induced apoptosis is involved in cell-to-cell spread of<i>Mycobacterium tuberculosis</i>

Henar Alonso, Santiago Uranga, Dessislava Marinova et al. · Cellular Microbiology · 2013 · 141 citations · Full text

Apoptosis, Immunology, Immune Regulation +18

Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis

Nacho Aguiló, Jesús Gonzalo‐Asensio, Samuel Álvarez-Arguedas et al. · Nature Communications · 2017 · 134 citations · Full text

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial

Michèle Tameris, Helen Mearns, Adam Penn‐Nicholson et al. · The Lancet Respiratory Medicine · 2019 · 134 citations · Full text

Vaccination, Vaccine Safety, Pulmonary Tuberculosis +7